2019 ICPE Presentation: Analysis of SGLT2 Inhibitor Use in Patients with Type-1 Diabetes Mellitus and Rates of Diabetic Ketoacidosis

Project Title 2019 ICPE Presentation: Analysis of SGLT2 Inhibitor Use in Patients with Type-1 Diabetes Mellitus and Rates of Diabetic Ketoacidosis
Date
Monday, August 26, 2019
Location
Medical Product
sodium-glucose cotransporter-2 (SGLT-2) inhibitor
Health Outcome
diabetic ketoacidosis
Host
Authors

Christian Hampp

Related Assessments